Single Dose Study of ANX005 in Healthy Volunteers

NCT03010046 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

27

Enrollment

INDUSTRY

Sponsor class

Stopped ANX005 well tolerated at doses studied; study discontinued and initiated in patient population

Conditions

Safety and Tolerability in Healthy Volunteers

Interventions

DRUG: ANX005
DRUG: IVIg
DRUG: Placebos

Sponsor

Annexon, Inc.